267 related items for PubMed ID: 12364444
1. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
Grottoli S, Giordano R, Maccagno B, Pellegrino M, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
[Abstract] [Full Text] [Related]
2. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E, Maccagno B, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[Abstract] [Full Text] [Related]
3. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, Ghigo E, Arvat E.
Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
[Abstract] [Full Text] [Related]
4. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.
Giordano R, Bo M, Pellegrino M, Vezzari M, Baldi M, Picu A, Balbo M, Bonelli L, Migliaretti G, Ghigo E, Arvat E.
J Clin Endocrinol Metab; 2005 Oct; 90(10):5656-62. PubMed ID: 16014406
[Abstract] [Full Text] [Related]
5. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E.
J Clin Endocrinol Metab; 1999 Aug; 84(8):2611-5. PubMed ID: 10443648
[Abstract] [Full Text] [Related]
6. Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans.
Grottoli S, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, DeStefanis S, Camanni F, Ghigo E, Arvat E.
J Endocrinol Invest; 2002 May; 25(5):420-5. PubMed ID: 12035937
[Abstract] [Full Text] [Related]
7. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[Abstract] [Full Text] [Related]
8. Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans.
Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E.
Neuroendocrinology; 1998 May; 67(5):310-6. PubMed ID: 9641612
[Abstract] [Full Text] [Related]
9. Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans.
Giordano R, Pellegrino M, Picu A, Bonelli L, Oleandri SE, Pellissetto C, Limone P, Migliaretti G, Maccario M, Ghigo E, Arvat E.
J Endocrinol Invest; 2007 May; 30(7):558-63. PubMed ID: 17848838
[Abstract] [Full Text] [Related]
10. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans.
Wellhoener P, Born J, Fehm HL, Dodt C.
J Clin Endocrinol Metab; 2004 Oct; 89(10):5048-52. PubMed ID: 15472204
[Abstract] [Full Text] [Related]
11. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M, Allolio B, Würth G, Winkelmann W.
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[Abstract] [Full Text] [Related]
12. Increased neuroendocrine reactivity and decreased brain mineralocorticoid receptor-binding capacity in aged dogs.
Rothuizen J, Reul JM, van Sluijs FJ, Mol JA, Rijnberk A, de Kloet ER.
Endocrinology; 1993 Jan; 132(1):161-8. PubMed ID: 8380372
[Abstract] [Full Text] [Related]
13. Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.
Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F.
Psychoneuroendocrinology; 2000 Jul; 25(5):513-8. PubMed ID: 10818284
[Abstract] [Full Text] [Related]
14. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.
Wilkinson CW, Peskind ER, Raskind MA.
Neuroendocrinology; 1997 Jan; 65(1):79-90. PubMed ID: 9032777
[Abstract] [Full Text] [Related]
15. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H.
J Clin Endocrinol Metab; 1998 Sep; 83(9):3339-45. PubMed ID: 9745451
[Abstract] [Full Text] [Related]
16. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
Alexander SL, Irvine CH, Donald RA.
Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
[Abstract] [Full Text] [Related]
17. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
Brigell DF, Fang VS, Rosenfield RL.
J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844
[Abstract] [Full Text] [Related]
18. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans.
Dodt C, Kern W, Fehm HL, Born J.
Neuroendocrinology; 1993 Nov; 58(5):570-4. PubMed ID: 8115025
[Abstract] [Full Text] [Related]
19. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
[Abstract] [Full Text] [Related]
20. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.
Abelson JL, Young EA.
Psychoneuroendocrinology; 2003 Feb; 28(2):169-80. PubMed ID: 12510010
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
